CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Loxam Teri Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-06-01 | Drapeau Anne S Director | Grant or award | +3,125 | 3,125 | ||
| 2022-06-01 | Drapeau Anne S Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-06-01 | Lukatch Heath Director | Grant or award | +3,125 | 3,125 | ||
| 2022-06-01 | Lukatch Heath Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-06-01 | Hirth Peter Director | Grant or award | +3,125 | 3,125 | ||
| 2022-06-01 | Hirth Peter Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-06-01 | Gilbert Halley E Director | Grant or award | +3,125 | 3,125 | ||
| 2022-06-01 | Gilbert Halley E Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 | ||
| 2022-05-23 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $26.22 | $79K | 23,687 |
| 2022-05-20 | Fairman Jeff VP, Research | Sale | −4,112 | $25.50 | $105K | 321,227 |
| 2022-05-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion | +3,100 | $5.35 | $17K | 45,287 |
| 2022-05-18 | GUGGENHIME ANDREW President and CFO | Sale | −2,520 | $24.26 | $61K | 42,767 |
| 2022-05-18 | GUGGENHIME ANDREW President and CFO | Sale | −580 | $25.22 | $15K | 42,187 |
| 2022-05-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion · Stock Option (right to buy) | −3,100 | 502,918 | ||
| 2022-05-16 | PICKERING GRANT Chief Executive Officer | Exercise or conversion | +11,000 | $1.79 | $20K | 714,894 |
| 2022-05-16 | PICKERING GRANT Chief Executive Officer | Sale | −7,866 | $23.76 | $187K | 707,028 |
| 2022-05-16 | PICKERING GRANT Chief Executive Officer | Sale | −3,134 | $24.28 | $76K | 703,894 |
| 2022-05-16 | PICKERING GRANT Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −11,000 | 234,450 | ||
| 2022-05-09 | Eydelman Mikhail SVP, Gen Counsel & Corp Sec | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 |
Page 48 of 51 · 1,004 trades